Meta-Analysis Links Omega-3 Fatty Acid Consumption to T2DM

Share this content:
Meta-Analysis Links Omega-3 Fatty Acid Consumption to T2DM
Meta-Analysis Links Omega-3 Fatty Acid Consumption to T2DM

THURSDAY, Jan. 5, 2017 (HealthDay News) -- Consumption of single omega-3 is associated with an increased risk of type 2 diabetes (T2D), with dosage, ethnicity, trial duration, and recruited age influencing the effect, according to a meta-analysis published online Dec. 29 in the Journal of Diabetes Investigation.

Cai Chen, from the Huazhong University of Science & Technology in China, and colleagues conducted a meta-analysis based on prospective cohorts to examine the effect of omega-3 fatty acids on the risk of T2D. They calculated pooled risk using a fixed or random effects model.

The researchers found that consumption of single omega-3 correlated with increased risk of T2D (relative risk, 1.45); the relative risk was statistically insignificant for mixed omega-3. For diabetes risk, the dose-response curve presented an inverted U-shape, corresponding to omega-3 consumption dose. In subanalysis, omega-3 was inversely associated with the risk of T2D in Asians (relative risk, 0.82); in Westerners the risk was increased (relative risk, 1.3). A positive association was seen between T2D risk and omega-3 intake in studies with follow-up duration ≥16 years and baseline age ≥54 years.

"Our findings suggest that dosage and composition of omega-3, ethnicity, trial duration and recruited age may influence the effect of omega-3 on T2D progression," the authors write.

The study was partially funded by CIMF-Novo Nordisk.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Illicit Marijuana Use Up in States With Legal Medical Use

Illicit Marijuana Use Up in States With Legal ...

Cannabis use disorder is also rising faster in states with legalization laws

Chromosome Instability Test Prognostic in NSCLC

Chromosome Instability Test Prognostic in NSCLC

Chromosome instability associated with higher risk of relapse, death within 2 years

CDC: Opioid-Related Mortality Rate Might Be Underestimated

CDC: Opioid-Related Mortality Rate Might Be Underestimated

Death certificates from drug-linked infections may not label opioids as possible cause

is free, fast, and customized just for you!

Already a member?

Sign In Now »